Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-25-052366
Filing Date
2025-06-09
Accepted
2025-06-09 09:06:21
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4184
  Complete submission text file 0001213900-25-052366.txt   5781
Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
Moukheibir Catherine (Reporting) CIK: 0001772130 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39630 | Film No.: 251032953

Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Issuer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)